Literature DB >> 3936706

Chemical modification of DNA with muta-carcinogens. III. Reductive alkylation of DNA with mitomycin C.

Y Hashimoto, K Shudo.   

Abstract

Mitomycin C (MMC) binds to DNA after its reductive activation by catalytic hydrogenation with Pd on charcoal. Three modified nucleotides, named MG-1, MG-2, and MA, were isolated from the modified DNA after enzymatic hydrolysis to 5'-nucleotides. The structures of these modified nucleotides were deduced from their 1H-NMR and UV spectra, and from studies of the chemically transformed derivatives (hydrolysis, methylation, diazotization, and thioketonization). These three modified nucleotides were concluded to be 1,2-trans-2,7-diamino-1-(N2-deoxyguanylyl)mitosene (MG-1), 2,7-diamino-1-(O6-deoxyguanylyl)mitosene (MG-2) and 2,7-diamino-1-(N6-deoxyadenylyl)mitosene (MA). The same modified nucleotides were identified in DNA extracted from the livers of rats treated with MMC.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936706      PMCID: PMC1568724          DOI: 10.1289/ehp.8562219

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  2 in total

1.  Modification of deoxyribonucleic acid with reductively activated mitomycin C. Structures of modified nucleotides.

Authors:  Y Hashimoto; K Shudo; T Okamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-03       Impact factor: 1.645

Review 2.  Naturally occurring quinones as potential bioreductive alkylating agents.

Authors:  H W Moore; R Czerniak
Journal:  Med Res Rev       Date:  1981       Impact factor: 12.944

  2 in total
  3 in total

1.  Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System.

Authors:  Mark Jones; Marileila Varella-Garcia; Margaret Skokan; Steven Bryce; Jeffrey Schowinsky; Rebecca Peters; Boah Vang; Michelle Brecheisen; Thomas Startz; Nathan Frank; Brian Nankervis
Journal:  Cytotherapy       Date:  2013-08-28       Impact factor: 5.414

Review 2.  DNA adducts of medicinal drugs: some selected examples.

Authors:  M Metzler
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  Conversion of mitomycin C to 2,7-diaminomitosene and 10-decarbamoyl 2,7-diaminomitosene in tumour tissue in vivo.

Authors:  L Chirrey; J Cummings; G W Halbert; J F Smyth
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.